Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Multianalyte nano-biosensor diagnostics: advances through microfluidic and AI integration.

PMID: 41625077 · 2025

JournalFrontiers in bioengineering and biotechnology
Year2025
PMID41625077

Abstract

Recent advances in nano-biosensors are reshaping clinical diagnostics by enabling multiplexed biomarker detection with high sensitivity and precision. This mini-review examines both the opportunities and challenges in translating nano-biosensor technologies toward clinically relevant point-of-care (PoC) and wearable devices. We emphasize the integration of multiplexing strategies with microfluidic platforms and adaptive artificial intelligence (AI) algorithms, which together enable real-time, hi

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.